SouthState’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.54K Hold
8
– – ﹤0.01% 1035
2026
Q2
$1.09K Buy
8
+4
+100% +$491 ﹤0.01% 1095
2026
Q1
$472 Hold
4
– – ﹤0.01% 1193
2025
Q4
$656 Hold
4
– – ﹤0.01% 1189
2025
Q3
$535 Sell
4
-1
-20% -$121 ﹤0.01% 1227
2025
Q2
$622 Sell
5
-9
-64% -$1.14K ﹤0.01% 1380
2025
Q1
$1.78K Buy
+14
New +$2.16K ﹤0.01% 1213
2024
Q2
– Sell
-377
Closed -$69.3K – 747
2024
Q1
$69.3K Buy
+377
New +$71.8K 0.01% 347

Other funds holding RGEN

SouthState's RGEN Position: Q3 2026 in Review

SouthState held its Repligen (RGEN) position steady in Q3 2026 at 8 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

SouthState first reported a position in RGEN in Q1 2024 and has held it in 8 quarters since. The position peaked at $69.3K in Q1 2024. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • SouthState held 8 shares of Repligen worth $1.54K as of Q3 2026.
  • SouthState left its Repligen share count unchanged in Q3 2026.
  • Repligen made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1035 holding.
  • SouthState first reported a position in Repligen in Q1 2024 and has held it in 8 quarters since.
  • SouthState's Repligen position peaked at $69.3K in Q1 2024.
  • 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.